Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05615922

Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)

Conditions: Primary Progressive Aphasia

Sex: All
Ages: 45 Years – 80 Years
Phase: PHASE2
Enrollment: 30
Sponsor: NYU Langone Health

Location: United States

Summary

The purpose of this study is to establish the feasibility of a program of remotely supervised transcranial direct current stimulation (RS-tDCS) paired with language skills practice for people living with the semantic or logopenic variants of primary progressive aphasia (PPA). There are currently no established standard-of-care treatments for PPA. This study will evaluate whether RS-tDCS combined with language skills practice is a feasible study design for individuals with PPA.

Eligibility Criteria

Inclusion Criteria:Primary progressive aphasia diagnosis (logopenic or semantic variant)Peabody Picture Vocabulary Test (PPVT) score < -1.0 SD, serving as a literacy proxy for premorbid cognitive ability and ensuring English language fluency sufficient for participation in the study procedures.WAIS-IV Matrix Reasoning T score < 20, serving as an index of current general cognitive functioning to exclude those with severe cognitive impairmentStable and continuous access to internet service, email (WiFi "hotspot" to be provided if needed)Fluent in English language (due to outcomes validated in English versions only)Exclusion Criteria:Disorder other than PPA known to cause language dysfunctionDiagnosis of nonfluent/agrammatic subtype of primary progressive aphasiaHistory of traumatic brain injuryUncontrolled seizure disorder and/or recent (<5 years) history of seizureMetal implants in the head or neckAny skin disorder or skin sensitive area near stimulation locationsPregnant or breastfeeding

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05615922). StuddyBuddy aggregates publicly available trial information.